Erratum: Antidepressant-Like effect of sodium butyrate is associated with an increase in TET1 and in 5-Hydroxymethylation levels in the bdnf gene (International Journal of Neuropsychopharmacology (2015) 82:2 DOI: 10.1093/ijnp/pyu032);Antidepressant-like effect of sodium butyrate is associated with an increase in tet1 and in 5-hydroxymethylation levels in the BDNF gene

International Journal of Neuropsychopharmacology

Volumn 18, Issue 2, 2015, Pages 1-10

  Wei, Ya Bin ^a   Melas, Philippe A ^a   Wegener, Gregers ^b,c   Mathe, Aleksander A ^a   Lavebratt, Catharina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Depression; DNA methylation; Epigenetics; TET1

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; DIOXYGENASE; DNA; TEN ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 1; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; HISTONE DEACETYLASE INHIBITOR; TET1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CATALYSIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DNA HYDROXYMETHYLATION; DNA METHYLATION; DRUG EFFICACY; EPIGENETICS; FORCED SWIM TEST; MALE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; DEPRESSIVE DISORDER; DIOXYGENASES; DISEASE MODELS, ANIMAL; DNA METHYLATION; HISTONE DEACETYLASE INHIBITORS; MALE; PREFRONTAL CORTEX; RATS; UP-REGULATION;

EID: 84931261861     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv026     Document Type: Erratum

References (74)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85 525-535.
2. Angelucci F, Brene S, Mathe AA (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 10:345-352.
3. Benjamin D, Jost JP (2001) Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. Nucleic Acids Res 29:3603-3610.
4. Biard DS, Maratrat M, Thybaud V, Melcion C, Sarasin A (1992) Flow cytometric detection of drugs altering the DNA methylation pattern. Cancer Res 52:5213-5218.
5. Boffa LC, Mariani MR, Parker MI (1994) Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate. Exp Cell Res 211:420-423.
6. Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW, Kenis G (2012) Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17:584-596.
7. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14:268-276.
8. Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, Scandura JM (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLOS ONE 6:e14524.
9. Candido EP, Reeves R, Davie JR (1978) Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105-113.
10. Chiurazzi P, Pomponi MG, Pietrobono R, Bakker CE, Neri G, Oostra BA (1999) Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Gen 8:2317-2323.
11. Connolly KR, Thase ME (2012) Emerging drugs for major depressive disorder. EOMD 17:105-126.
12. Cosgrove DE, Cox GS (1990) Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines: variable response to drug treatment and withdrawal. Biochim Biophys Acta 1087:80-86.
13. Covington HE, 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451-11460.
14. de Haan JB, Gevers W, Parker MI (1986) Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res 46:713-716.
15. Detich N, Bovenzi V, Szyf M (2003) Valproate induces replication- independent active DNA demethylation. J Biol Chem 278:27586-27592.
16. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45:553-563.
17. Dwivedi Y, Rizavi HS, Pandey GN (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139:1017-1029.
18. Eriksson TM, Delagrange P, Spedding M, Popoli M, Mathe AA, Ogren SO, Svenningsson P (2012) Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry 17:173-184.
19. Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53:649-659.
20. Fischer CW, Liebenberg N, Elfving B, Lund S, Wegener G (2012) Isolation-induced behavioural changes in a genetic animal model of depression. Behav Brain Res 230:85-91.
21. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H] dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655-669.
22. Gomez-Galan M, De Bundel D, Van Eeckhaut A, Smolders I, Lindskog M (2013) Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression. Mol Psychiatry 18:582-594.
23. Graff J, Joseph NF, Horn ME, Samiei A, Meng J, Seo J, Rei D, Bero AW, Phan TX, Wagner F, Holson E, Xu J, Sun J, Neve RL, Mach RH, Haggarty SJ, Tsai LH (2014) Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories. Cell 156:261-276.
24. Grayson DR, Kundakovic M, Sharma RP (2010) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77:126-135.
25. Gu S, Tian Y, Chlenski A, Salwen HR, Lu Z, Raj JU, Yang Q (2012) Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma. Anticancer Drugs 23:1054-1066.
26. Guo JU, Su Y, Zhong C, Ming GL, Song H (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423-434.
27. Hansson AC, Rimondini R, Heilig M, Mathe AA, Sommer WH (2011) Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. J Psychopharmacol 25:1378-1387.
28. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19.
29. Insel TR (2012) Next-generation treatments for mental disorders. Sci Transl Med 4:155-119.
30. Jia P, Kao CF, Kuo PH, Zhao Z (2011) A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Syst Biol 5(Suppl 3):S12.
31. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, King JR, Song H, Sweatt JD (2013) TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79:1086-1093.
32. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
33. Klengel T, Pape J, Binder EB, Mehta D (2014) The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology Jan 19.
34. Kohli RM, Zhang Y (2013) TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472-479.
35. Kriaucionis S, Heintz N (2009) The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain. Science 324:929-930.
36. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, Russo SJ, Laplant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48:303-314.
37. Levine A, Huang Y, Drisaldi B, Griffin EA, Jr., Pollak DD, Xu S, Yin D, Schaffran C, Kandel DB, Kandel ER (2011) Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 3:107-109.
38. Lindfors C, Nilsson IA, Garcia-Roves PM, Zuberi AR, Karimi M, Donahue LR, Roopenian DC, Mulder J, Uhlen M, Ekstrom TJ, Davisson MT, Hokfelt TG, Schalling M, Johansen JE (2011) Hypothalamic mitochondrial dysfunction associated with anorexia in the anx/anx mouse. Proc Natl Acad Sci USA 108:18108-18113.
39. Lu JJ, Pan W, Hu YJ, Wang YT (2012) Multi-target drugs: the trend of drug research and development. PLOS ONE 7:e40262.
40. Lubin FD, Roth TL, Sweatt JD (2008) Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28:10576-10586.
41. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-893.
42. Melas PA, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A, Werme M, Wegener G, Mathe AA, Svenningsson P, Lavebratt C (2012) Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychop 15:669-679.
43. Melas PA, Lennartsson A, Vakifahmetoglu-Norberg H, Wei Y, Aberg E, Werme M, Rogdaki M, Mannervik M, Wegener G, Brene S, Mathe AA, Lavebratt C (2013) Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression. Transl Psychiatry 3:e255.
44. Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151:1417-1430.
45. Menke A, Klengel T, Binder EB (2012) Epigenetics, depression and antidepressant treatment. Curr Pharm Des 18:5879-5889.
46. Milutinovic S, D'Alessio AC, Detich N, Szyf M (2007) Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28:560-571.
47. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathe AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F (2013) L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci USA 110:4804-4809.
48. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH (2008) Functional organization of the transcriptome in human brain. Nat Neurosci 11:1271-1282.
49. Overstreet DH, Wegener G (2013) The flinders sensitive line rat model of depression-25 years and still producing. Pharmacol Rev 65:143-155.
50. Overstreet DH, Friedman E, Mathe AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739-759.
51. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729-3737.
52. Parker MI, de Haan JB, Gevers W (1986) DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem 261:2786-2790.
53. Peedicayil J, Kumar A (2012) Time for clinical trials of epigenetic drugs in psychiatric disorders? Br J Clin Pharmacol 73:309-310.
54. Ponomarev I, Wang S, Zhang L, Harris RA, Mayfield RD (2012) Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J Neurosci 32:1884-1897.
55. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336.
56. Ressler KJ, Mayberg HS (2007) Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10:1116-1124.
57. Robinson J, Sareen J, Cox BJ, Bolton J (2009) Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample. J Anxiety Disord 23:38-45.
58. Sales AJ, Biojone C, Terceti MS, Guimaraes FS, Gomes MV, Joca SR (2011) Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol 164:1711-1721.
59. Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV (2011) Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res 31:2723-2732.
60. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007) Antidepressant- like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62:55-64.
61. Sealy L, Chalkley R (1978) The effect of sodium butyrate on histone modification. Cell 14:115-121.
62. Serafini G (2012) Neuroplasticity and major depression, the role of modern antidepressant drugs. World J Psychiatry 2:49-57.
63. Shin H, Kim JH, Lee YS, Lee YC (2012) Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Int J Oncol 40:1533-1542.
64. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606.
65. Suliman S, Hemmings SM, Seedat S (2013) Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci 7:55.
66. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-935.
67. Takase K, Oda S, Kuroda M, Funato H (2013) Monoaminergic and neuropeptidergic neurons have distinct expression profiles of histone deacetylases. PLOS ONE 8:e58473.
68. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525.
69. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355-367.
70. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, Suzuki T, Miyata N, Watanabe Y (2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69:359-372.
71. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME (2001) Calcium regulation of neuronal gene expression. Proc Natl Acad Sci USA 98:11024-11031.
72. Wu SC, Zhang Y (2010) Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11:607-620.
73. Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S (2012) Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry 13:458-467.
74. Zhu H, Huang Q, Xu H, Niu L, Zhou JN (2009) Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors. Behav Brain Res 196:200-206.